Publications by authors named "Christian Kalberer"

Claim this Profile
P
Plasma cells with Auer-rod-like inclusions in a patient with MGUS and acute myeloid leukaemia with NPM1 mutation.
Janine Glanzmann, Christian Kalberer, Nicolas Bonadies, Giuseppe Colucci

Br J Haematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myeloma.
Astrid Tschan-Plessl, Christian P Kalberer, Ronja Wieboldt, Martin Stern, Uwe Siegler

Cytotherapy· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment: Shall Killer Cell Immunoglobulin-Like Receptor Genotyping be Incorporated in Donor Search Algorithms?
Jakob R Passweg, Christian P Kalberer

Biol Blood Marrow Transplant· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic modification of murine hematopoietic stem cells by retroviruses.
Christian P Kalberer, Jennifer Antonchuk, R Keith Humphries

Methods Mol Med· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-transcriptional regulation of ULBP1 ligand for the activating immunoreceptor NKG2D involves 3' untranslated region.
Heike Himmelreich, Arina Mathys, Aleksandra Wodnar-Filipowicz, Christian P Kalberer

Hum Immunol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients.
Uwe Siegler, Sandrine Meyer-Monard, Simon Jörger, Martin Stern, André Tichelli, Christian P Kalberer

Cytotherapy· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human acute myeloid leukemia CD34+CD38- stem cells are susceptible to allorecognition and lysis by single KIR-expressing natural killer cells.
Ulrich Langenkamp, Uwe Siegler, Simon Jörger, Stefan Diermayr, Alois Gratwohl, Christian P Kalberer

Haematologica· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical-grade purification of natural killer cells in haploidentical hematopoietic stem cell transplantation.
Sandrine Meyer-Monard, Jakob Passweg, Uwe Siegler, Christian Kalberer, Ulrike Koehl

Transfusion· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical stem-cell sources contain CD8+CD3+ T-cell receptor-negative cells that facilitate bone marrow repopulation with hematopoietic stem cells.
Stephanie Bridenbaugh, Linda Kenins, Emilie Bouliong-Pillai, Christian P Kalberer, Elena Shklovskaya

Blood· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities.
Stefan Diermayr, Heike Himmelreich, Bojana Durovic, Arina Mathys-Schneeberger, Uwe Siegler, Christian P Kalberer

Blood· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis.
Andreas Rohner, Ulrich Langenkamp, Uwe Siegler, Christian P Kalberer, Aleksandra Wodnar-Filipowicz

Leuk Res· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normal erythropoiesis but severe polyposis and bleeding anemia in Smad4-deficient mice.
Dejing Pan, Tibor Schomber, Christian P Kalberer, Luigi M Terracciano, Katrin Hafen

Blood· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Function of natural killer cells in immune defence against human leukaemia.
A Wodnar-Filipowicz, Christian P Kalberer

Swiss Med Wkly· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of silencing NKG2D through RNA interference on receptor functions in interleukin-2-activated human natural killer cells.
Vanessa Baeriswyl, Aleksandra Wodnar-Filipowicz, Christian P Kalberer

Haematologica· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Function of natural killer cells in immune defence against human leukaemia.
A Wodnar-Filipowicz, Christian P Kalberer

Swiss Med Wkly· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias.
Pegah Nowbakht, Mihai-Constantin S Ionescu, Andreas Rohner, Christian P Kalberer, Emmanuel Rossy

Blood· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene silencing by lentivirus-mediated delivery of siRNA in human CD34+ cells.
Tibor Schomber, Christian P Kalberer, Aleksandra Wodnar-Filipowicz, Radek C Skoda

Blood· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human NK cell development in NOD/SCID mice receiving grafts of cord blood CD34+ cells.
Christian P Kalberer, Uwe Siegler, Aleksandra Wodnar-Filipowicz

Blood· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of using autologous transplantation to evaluate hematopoietic stem cell-based gene therapy strategies in transgenic mouse models of human disease.
Cindy L Miller, Suzan Imren, Jennifer Antonchuk, Christian Kalberer, Mary E Fabry

Mol Ther· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis